MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-06-0024967
Clinivex Pharmaceuticals Private Limited
Clinivex Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹61.32 Cr
▲ 6% YoY
Net profit · FY 2024
₹18.92 Lakh
Net margin 0.3%
EBITDA · FY 2024
₹75.79 Lakh
EBITDA margin 1.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹4.78 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Clinivex Pharmaceuticals Private Limited
Data last updated:
Clinivex Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC354326. Its GSTIN is 07AAICC3509M1ZH (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Kajal Jain and Pradip Jain.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at House No 307 & 308 Upper Ground Floor Sec – 21 Rohini Landmark Near Dda Park, New Delhi, Delhi, India – 110086.
As per the financials filed for FY 2024, the company reported a revenue of ₹61.32 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹18.92 Lakh (net margin 0.3%) and EBITDA of ₹75.79 Lakh (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.
As per MCA filings, the company has open charges of ₹4.78 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
Clinivex Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0024967).
Company details
CIN U24230DL2019PTC354326
Registration Number 354326
Incorporation Date 27 August 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Medium
Udyam Registration UDYAM-DL-06-0024967
Key People
Kajal Jain Director Pradip Jain Director Recognitions & Rankings of Clinivex Pharmaceuticals
Contact details
Clinivex Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No 307 & 308 Upper Ground Floor Sec – 21 Rohini Landmark Near Dda Park, New Delhi, Delhi, India – 110086
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Clinivex Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Clinivex Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Clinivex Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Clinivex Pharmaceuticals Private Limited, buy the company report.
Financials of Clinivex Pharmaceuticals Private Limited
FY 2024 filings availableClinivex Pharmaceuticals Private Limited reported revenue of ₹61.32 Cr (up 6% YoY) for FY 2024.
Revenue · FY 2024
₹61.32 Cr ▲ 6%
Net profit · FY 2024
₹18.92 Lakh margin 0.3%
EBITDA · FY 2024
₹75.79 Lakh margin 1.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 74%
Revenue has grown at a compounded annual rate (CAGR) of 24% over three years, including 6% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹75.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Clinivex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Clinivex Pharmaceuticals Private Limited
Clinivex Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kajal Jain | Director | 27 Aug 2019 | 7 Years 2 Months | Current |
| Pradip Jain | Director | 27 Aug 2019 | 7 Years 2 Months | Current |
Auditor
Clinivex Pharmaceuticals Private Limited is audited by Shakti Sharan & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Shakti Sharan & Company | FY 2023 | 012809C |
Shareholding
The shareholding of Clinivex Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Clinivex Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.78 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Sep 2020 | 100378217 | Others | ₹4.78 Cr | Open |
To see the full charge records of Clinivex Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Clinivex Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Clinivex Pharmaceuticals. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against Nuelife Healthcare Pharmaceuticals | Pending |
To see the full case history of Clinivex Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Clinivex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Clinivex Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICC3509M1ZH | Delhi | Active | 11 Oct 2019 |
To see the full GST registrations and return filing status of Clinivex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Clinivex Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Kajal Jain was appointed as Director on 27 Aug 2019.
AGM
Clinivex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Clinivex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Others of Rs. 477.60 Lakh registered on 22 Sep 2020 with Charge ID 100378217 was modified on 30 Jan 2024.
Charges
A charge with Others amounted to Rs. 477.60 Lakh with Charge ID 100378217 was registered on 22 Sep 2020.
Appointed
Kajal Jain was appointed as Director.
Appointed
Pradip Jain was appointed as Director.
Incorporation
27 Aug 2019
Clinivex Pharmaceuticals Private Limited was registered on 27 Aug 2019 with Roc Delhi & aged 7 years 2 months as per MCA records.
Frequently asked questions
Clinivex Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 August 2019 (7+ years old) and is registered under CIN U24230DL2019PTC354326.
Clinivex Pharmaceuticals has 2 current directors:
- Kajal Jain - Director
- Pradip Jain - Director
The latest financial statements of Clinivex Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Clinivex Pharmaceuticals is 07AAICC3509M1ZH, registered in Delhi.
The CIN (Corporate Identification Number) of Clinivex Pharmaceuticals is U24230DL2019PTC354326. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clinivex Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.
Clinivex Pharmaceuticals was incorporated on 27 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Kajal Jain was appointed as Director on 27 Aug 2019. Pradip Jain was appointed as Director on 27 Aug 2019.
Yes, Clinivex Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-06-0024967).
The registered office of Clinivex Pharmaceuticals is at House No 307 & 308 Upper Ground Floor Sec – 21 Rohini Landmark Near Dda Park, New Delhi, Delhi, India – 110086.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages